Cybin CYBN Stock
Cybin Price Chart
Cybin CYBN Financial and Trading Overview
| Cybin stock price | 8.28 USD |
| Previous Close | 8.18 USD |
| Open | 8.27 USD |
| Bid | 0 USD x 40000 |
| Ask | 0 USD x 30000 |
| Day's Range | 8.14 - 8.38 USD |
| 52 Week Range | 4.81 - 10.72 USD |
| Volume | 716.53K USD |
| Avg. Volume | 870.66K USD |
| Market Cap | 413.12M USD |
| Beta (5Y Monthly) | 0.793 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 48.55 USD |
CYBN Valuation Measures
| Enterprise Value | 330.82M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.8237495 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.5549296 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.351 |
Trading Information
Cybin Stock Price History
| Beta (5Y Monthly) | 0.793 |
| 52-Week Change | -15.22% |
| S&P500 52-Week Change | 18.37% |
| 52 Week High | 10.72 USD |
| 52 Week Low | 4.81 USD |
| 50-Day Moving Average | 6.85 USD |
| 200-Day Moving Average | 7.05 USD |
CYBN Share Statistics
| Avg. Volume (3 month) | 870.66K USD |
| Avg. Daily Volume (10-Days) | 549.08K USD |
| Shares Outstanding | 49.89M |
| Float | 38.55M |
| Short Ratio | 2.07 |
| % Held by Insiders | 6.01% |
| % Held by Institutions | 27.08% |
| Shares Short | 2.43M |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 4.86% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:38 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2025 |
| Most Recent Quarter (mrq) | September 30, 2025 |
| Next Fiscal Year End | March 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -32.86% |
| Return on Equity (ttm) | -52.96% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -98725328 USD |
| Net Income Avi to Common (ttm) | -86798672 USD |
| Diluted EPS (ttm) | -3.77 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 83.75M USD |
| Total Cash Per Share (mrq) | 1.68 USD |
| Total Debt (mrq) | 28.89M USD |
| Total Debt/Equity (mrq) | 20.78 USD |
| Current Ratio (mrq) | 8.575 |
| Book Value Per Share (mrq) | 5.325 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -97757512 USD |
| Levered Free Cash Flow (ttm) | -65267852 USD |
Profile of Cybin
| Country | United States |
| State | ON |
| City | Toronto |
| Address | 100 King Street West |
| ZIP | M5X 1C9 |
| Phone | N/A |
| Website | https://cybin.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 50 |
Cybin Inc., a clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions. It develops CYB003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and CYB004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders. The company also develops SPL028 injectable deuterated DMT completed phase 1 clinical intramuscular and intravenous trial; SPL026 for MDD; and CYB005, a phenethylamine derivative, which in preclinical stage to treat central nervous system, as well as has a research pipeline of investigational psychedelic-based compounds. It has a strategic partnership agreement with Segal Trials to support PARADIGM, a multinational pivotal phase 3 program evaluating CYB003 for the adjunctive treatment of major depressive disorder. The company is headquartered in Toronto, Canada.
Q&A For Cybin Stock
What is a current CYBN stock price?
Cybin CYBN stock price today per share is 8.28 USD.
How to purchase Cybin stock?
You can buy CYBN shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cybin?
The stock symbol or ticker of Cybin is CYBN.
Which industry does the Cybin company belong to?
The Cybin industry is Biotechnology.
How many shares does Cybin have in circulation?
The max supply of Cybin shares is 49.89M.
What is Cybin Price to Earnings Ratio (PE Ratio)?
Cybin PE Ratio is 0.00000000 now.
What was Cybin earnings per share over the trailing 12 months (TTM)?
Cybin EPS is 0 USD over the trailing 12 months.
Which sector does the Cybin company belong to?
The Cybin sector is Healthcare.